Clariane SEFRA:KO2 +0.19%60 FCF Yield % is 55.76 as of Jun. 30, 2026, which is 329% above its 10-year median of 13.00. GuruFocus rates FRA:KO2 with a GF Score™ of 60/100 and a GF Value™ of €2.47 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 684 Healthcare Providers & Services companies, Clariane SE ranks better than 98.68% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Clariane SE's FCF Yield % or its related term are showing as below:
FRA:KO2'
s FCF Yield % Range Over the Past 10 Years
Min: 3.03 Med: 13 Max: 198.43
Current: 55.76
During the past 13 years, the highest FCF Yield % of Clariane SE was 198.43%. The lowest was 3.03%. And the median was 13.00%.
FRA:KO2's FCF Yield % is ranked better than 98.68% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 1.92
vs FRA:KO2: 55.76
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Clariane SE FCF Yield % Related Terms
Clariane SE FCF Yield % Historical Data
* Premium members only.
The historical data trend for Clariane SE's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Clariane SE's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Clariane SE's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (FRA:KO2) has a FCF Yield % of 55.76 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clariane SE and its competitors. This is 329% above median its historical median of 13.00. Over the past decade, Clariane SE's FCF Yield % has ranged from 3.03 to 198.43. According to the industry distribution chart, Clariane SE ranks #9 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 1.3%.
Is Clariane SE's FCF Yield % too high?
Clariane SE's current FCF Yield % of 55.76 is 329% above median its 10-year median of 13.00. Over the past 10 years, this metric has ranged from a low of 3.03 to a high of 198.43. The Healthcare Providers & Services industry median FCF Yield % is 1.92. Clariane SE's value of 55.76 is 2804.2% above this industry median. Based on the distribution chart, Clariane SE ranks #9 out of 684 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's FCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #9 out of 684 companies for FCF Yield %. This places Clariane SE in the top 1% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.92. Clariane SE's value of 55.76 is 2804.2% above this benchmark. Historically, Clariane SE's own FCF Yield % has ranged from 3.03 to 198.43 over the past decade. While the company's 10-year median is 13.00 vs. the industry median of 1.92, Clariane SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.92, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current FCF Yield % of 55.76 is 2804.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current FCF Yield % is 55.76, which is 329% above median its own 10-year median of 13.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (FRA:KO2) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.47, compared to a current price of €4.21 — trading 70.4% above its estimated fair value. The current FCF Yield % is 55.76, which is 329% above median its 10-year median of 13.00 and 2804.2% above the Healthcare Providers & Services industry median of 1.92. Clariane SE's overall GF Score™ is 60/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Clariane SE (FRA:KO2), the current FCF Yield % is 55.76 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (FRA:KO2) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.21 is trading 70.4% above its estimated GF Value™ of €2.47.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for FRA:KO2:
FCF Yield %: 55.76 (329% above median its 10-year median of 13.00)
GF Value™: €2.47 vs. price of €4.21 (70.4% above fair value)
Industry Position: 2804.2% above the Healthcare Providers & Services median (#9 of 684)
No single metric tells the full story. See the FRA:KO2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
60GF Score
Get the complete analysis for FRA:KO2
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:KO2 has been successfully added to your 
